intravenous relenza, page-7

Yes TJW you are probably correct, it would be a less biased route and more logical, for IV Relenza.

I was just running Ranbaxy by you as a possible partner in India to GSK.........they have an ease of use Inhalers and API Manufacturer, I was thinking there maybe a link for Relenza and the Indian market? I don,t know much about the GSK Indian market except for what I read in the article, GSK seems to have 25% of the prescription market, there.

Thanks for your reply, I don,t think I would be posting on here except for your knowledge to bounce things off, in fact I wouldn,t be here except for your posts.

Cheers dma